More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
AUM
$966285448
P/E ratio
--
Dividend yield
11.2477%
Expense ratio
1.19%
Beta
0.776901
Previous close
$20.29
Today's open
$20.23
Day's range
$20.12 - $20.48
52 week range
$17.14 - $24.85
Industries
Health
AMGN
Amgen Inc
3.4%
QURE:AS
Uniqure Nv
3.1%
2.8%
PCVX
Vaxcyte Inc
2.5%
INSM
Insmed Inc
2.3%
2.1%
1.9%
1.8%
1.8%
Real Estate On Sale: Locking In +9% Cash Yields
Elevated interest rates push property cap rates higher, creating historically attractive entry multiples for institutional REIT buyers. CEFs transform low-yielding institutional REIT holdings into monthly cash checks. Cohen & Steers Quality Income Realty Fund Inc. holds high-conviction stakes in premier blue-chip REITs, consistently outperforming the passive VNQ benchmark across full economic cycles.
Seeking Alpha • Sep 19, 2026

HQH: Over 10% Yield On This Healthcare Fund
HQH benefits from healthcare sector mean reversion after lagging the broader market for a decade. abrdn Healthcare Investors provides a lucrative 12% forward distribution yield backed by a managed distribution policy. HQH focuses primarily on small and mid cap biotech while incorporating select larger cap holdings.
Seeking Alpha • Sep 18, 2026

Opportunity To Catch 2 Income Picks Before Their Yield Goes Higher
The "Base + Commission" Portfolio: Combining fixed-rate debt and preferreds with formulaic, NAV-linked variable CEFs creates a solid baseline of income with automated upside during bull markets. RVT's quarterly payout is tracking up from $0.31 to $0.33 in September, with additional regular and special year-end dividend upside in play. HQH's September payout is set to reach $0.66 per share – its highest single quarterly distribution since 2015 – with strong potential for a year-end special distribution.
Seeking Alpha • Aug 22, 2026

HQH: After Biotech's Breakout Year, This Healthcare CEF Still Trades Below NAV; Buy
Abrdn Healthcare Investors is a concentrated, actively managed biotech-focused CEF trading at a 6.4% discount to NAV. I rate HQH a Buy: the fund delivered a 56% NAV return in twelve months, benefiting from an FDA regulatory shift and M&A tailwinds. The near-12% distribution is entirely funded by realized gains, not return of capital, distinguishing HQH from most high-payout CEFs.
Seeking Alpha • Aug 7, 2026

2 Lower-Risk Fat Dividends You Can't Ignore
There is no universally "best" investment; successful portfolios combine complementary strengths. We discuss why dependable dividends are essential to long-term wealth creation. Our two high-yield picks provide reliable income from very different corners of the market; yields +6%.
Seeking Alpha • Aug 3, 2026

Establishing A High-Yield Portfolio For Any Economic Conditions
Managed, leveraged fixed-income funds offer liquidity and instant diversification across thousands of complex institutional credit facilities. Strengthening demographic demand from an aging U.S. population delivers acyclical structural tailwinds to healthcare investments. Broad closed-end funds convert standard large- and small-cap stock movements into highly visible, managed distributions.
Seeking Alpha • Jul 20, 2026

Ride The Silver Tsunami With Big Dividends; Yields +8%
Healthcare sector demand is set to surge due to global aging and declining fertility rates, driving resilient, long-term growth opportunities. As income investors, even with the most powerful tailwinds, we seek means to secure steady cash flows from our investments. We discuss our top picks to ride the Silver Tsunami, with yields +8%.
Seeking Alpha • Jun 23, 2026

The Withdrawal Trap: Why Paper Wealth Fails Retirees
Always build your portfolio around your unique lifestyle goals—don't end up standing on a beach in snow pants. Mimicking ultra-wealthy founders is dangerous. Billionaires have completely different financial goals, skills, and timelines than retirees. Warren Buffett's empire relies on controlling operating companies and a massive Treasury bill hoard, not simple stock-picking.
Seeking Alpha • Jun 6, 2026

HQH: GLP-1 Market Growth Offers Upside But Portfolio Structure A Bit Inefficient
abrdn Healthcare Investors offers diversified healthcare exposure with a high yield, but structural inefficiencies persist. HQH trades near its narrowest historical discount to NAV, making current valuation less attractive versus its five-year average. The fund's high payout relies on net realized gains, risking NAV erosion and inconsistent dividend coverage during sector downturns.
Seeking Alpha • May 20, 2026

Variable Payouts, Permanent Income: Why I'm Buying These 11% Yields Today
Variable policies prevent funds from over-distributing and eroding the long-term capital base. HQH: Secure a 3% quarterly payout from the cutting edge of biotech and pharmaceutical innovation. USA: Get broad, large-cap exposure while maintaining a double-digit yield through five elite management teams.
Seeking Alpha • Apr 22, 2026

¹ Disclosures

Open an M1 investment account to buy and sell abrdn Healthcare Investors Shares of Beneficial Interest commission-free¹. Build wealth for the long term using automated trading and transfers.